title: Succesful treatment of chronic hepatitis C virus infection with daclatasvir and asunaprevir in a transfusion dependent thalassaemia patient.
authors.forename: H
authors.initials: H
authors.lastname: Köklü
authors.forename: S
authors.initials: S
authors.lastname: Köklü
authors.forename: O
authors.initials: O
authors.lastname: Ozturk
authors.forename: E K
authors.initials: EK
authors.lastname: Aksoy
authors.forename: N
authors.initials: N
authors.lastname: Tseveldorj
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage; D001803:Blood Transfusion / Q000379:methods; D002219:Carbamates; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D007546:Isoquinolines / Q000008:administration & dosage*; D008297:Male; D011759:Pyrrolidines; D013449:Sulfonamides / Q000008:administration & dosage*; D013789:Thalassemia / Q000628:therapy*; D065227:Transfusion Reaction; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives
chemical_list: D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D007546:Isoquinolines; D011759:Pyrrolidines; D013449:Sulfonamides; D014633:Valine; C549273:daclatasvir; C571889:asunaprevir